慢性硬膜下血肿手术中人工脑脊液术中冲洗疗效:多中心随机对照试验研究方案
本研究为日本19个神经外科部门开展的多中心随机对照试验,计划纳入1186例慢性硬膜下血肿患者,随机分为术中人工脑脊液冲洗组与不冲洗组,两组术后均放置硬膜下引流至少12小时。主要终点为术后6个月内符合同侧再手术标准的患者比例,冲洗组预期7%、非冲洗组预期12%。
要点
- 慢性硬膜下血肿术后复发比例仍高达10%至20%。
- 研究假设术中冲洗液选择可能是影响手术结局的关键因素。
- 主要终点为术后6个月内符合同侧再手术标准的患者比例。
核心结论
- 本研究方案旨在验证术中人工脑脊液冲洗较不冲洗可降低慢性硬膜下血肿清除术后复发比例的假设。
研究设计与样本
- 多中心随机对照试验,在日本19个神经外科部门开展,计划纳入1186例 eligible 患者。
- 患者随机分配至术中人工脑脊液冲洗组或不冲洗组,两组术后均放置硬膜下引流至少12小时。
主要发现
- 参考文献设定冲洗组符合同侧再手术标准的患者比例为7%,非冲洗组为12%。
- 主要终点为术后6个月内符合同侧再手术标准的患者比例,标准为临床症状恶化且影像学显示血肿较术后状态增大。
- 次要终点包括术后6个月内再手术比例、按术前CT血肿结构分层比例、神经症状、患者状况、6个月死亡率、手术相关并发症、术后至出院住院时间及手术时间。
关键数值与推荐
- 主要终点:术后6个月内符合同侧再手术标准的患者比例,冲洗组设定7% vs 非冲洗组设定12%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The surgical techniques for treatment of chronic subdural hematoma (CSDH), a common neurosurgical condition, have been discussed in a lot of clinical literature. However, the recurrence proportion after CSDH surgery remains high, ranging from 10 to 20%. The standard surgical procedure for CSDH involves a craniostomy to evacuate the hematoma, but irrigating the hematoma cavity during the procedure is debatable. The authors hypothesized that the choice of irrigation fluid might be a key factor affecting the outcomes of surgery. This multicenter randomized controlled trial aims to investigate whether intraoperative irrigation using artificial cerebrospinal fluid (ACF) followed by the placement of a subdural drain would yield superior results compared to the placement of a subdural drain alone for CSDH. METHODS: The study will be conducted across 19 neurosurgical departments in Japan. The 1186 eligible patients will be randomly allocated to two groups: irrigation using ACF or not. In either group, a subdural drain is to be placed for at least 12 h postoperatively. Similar to what was done in previous studies, we set the proportion of patients that meet the criteria for ipsilateral reoperation at 7% in the irrigation group and 12% in the non-irrigation group. The primary endpoint is the proportion of patients who meet the criteria for ipsilateral reoperation within 6 months of surgery (clinical worsening of symptoms and increased hematoma on imaging compared with the postoperative state). The secondary endpoints are the proportion of reoperations within 6 months, the proportion being stratified by preoperative hematoma architecture by computed tomography (CT) scan, neurological symptoms, patient condition, mortality at 6 months, complications associated with surgery, length of hospital stay from surgery to discharge, and time of the surgical procedure. DISCUSSION: We present the study protocol for a multicenter randomized controlled trial to investigate our hypothesis that intraoperative irrigation with ACF reduces the recurrence proportion after the removal of chronic subdural hematomas compared with no irrigation. TRIAL REGISTRATION: ClinicalTrials.gov jRCT1041220124. Registered on January 13, 2023.
引用
- Nagashima Y, Araki Y, Nishida K, et al. Efficacy of intraoperative irrigation with artificial cerebrospinal fluid in chronic subdural hematoma surgery: study protocol for a multicenter randomized controlled trial. Trials. 2024. PMID: 38166992. doi:10.1186/s13063-023-07889-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。